Detailed answers about DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD, including incorporation, status, business activity, and accounts information.
When was DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD founded?
DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD was officially incorporated on 16 September 2025 and is registered under company number 16722555. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD?
DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD do?
DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD operates in the following sector: 70229 - Management consultancy activities other than financial management. This provides insight into the company's primary business activity and industry focus.
What is DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD's registered address?
The registered office address of DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD is 8 TILSTONE AVENUE, ETON WICK, WINDSOR, ENGLAND, SL4 6NF. This is the official address filed with Companies House for legal and statutory correspondence.
Is DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD financially stable?
Financial accounts for DELANEY PHARMACEUTICAL CONSULTING (DPC) LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.